Lv11
20 积分 2022-05-09 加入
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
5小时前
待确认
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
2个月前
已完结
Exploring the next generation of antibody-drug conjugates
3个月前
已完结
MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals
5个月前
已完结
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers. A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
6个月前
已完结
Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity
6个月前
已完结
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
6个月前
已完结
Stability of Ala 125 recombinant human interleukin-2 in solution
8个月前
已完结
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis
9个月前
已完结
皖公网安备34019202002308
